These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34849412)

  • 21. Early experience with MR-guided adaptive radiotherapy using a 1.5 T MR-Linac: First 6 months of operation using adapt to shape workflow.
    de Leon J; Crawford D; Moutrie Z; Alvares S; Hogan L; Pagulayan C; Jelen U; Loo C; Aylward JD; Condon K; Dunkerley N; Heinke MY; Sampaio S; Simon K; Twentyman T; Jameson MG
    J Med Imaging Radiat Oncol; 2022 Feb; 66(1):138-145. PubMed ID: 34643065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feasibility of Adaptive MR-guided Stereotactic Body Radiotherapy (SBRT) of Lung Tumors.
    Padgett KR; Simpson GN; Llorente R; Samuels MA; Dogan N
    Cureus; 2018 Apr; 10(4):e2423. PubMed ID: 29872603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of Isotoxic Dose Escalation and Plan Quality with TDABC Analysis on a 0.35 T MR-Linac (MRL) System in Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided Radiation Therapy (MRgRT) for Primary Pancreatic Cancer.
    Hawranko R; Sohn JJ; Neiderer K; Bump E; Harris T; Fields EC; Weiss E; Song WY
    J Clin Med; 2022 May; 11(9):. PubMed ID: 35566712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Online Adaptive MRI-Guided Stereotactic Body Radiotherapy for Pancreatic and Other Intra-Abdominal Cancers.
    Lee D; Renz P; Oh S; Hwang MS; Pavord D; Yun KL; Collura C; McCauley M; Colonias AT; Trombetta M; Kirichenko A
    Cancers (Basel); 2023 Nov; 15(21):. PubMed ID: 37958447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Unity 1.5 T MR-linac plan quality in patients with prostate cancer.
    Tanaka S; Kadoya N; Ishizawa M; Katsuta Y; Arai K; Takahashi H; Xiao Y; Takahashi N; Sato K; Takeda K; Jingu K
    J Appl Clin Med Phys; 2023 Dec; 24(12):e14122. PubMed ID: 37559561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new workflow of the on-line 1.5-T MR-guided adaptive radiation therapy.
    Uno T; Tsuneda M; Abe K; Fujita Y; Harada R; Saito M; Kanazawa A; Kodate A; Abe Y; Ikeda Y; Nemoto MW; Yokota H
    Jpn J Radiol; 2023 Nov; 41(11):1316-1322. PubMed ID: 37354344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First clinical experiences with a high field 1.5 T MR linac.
    Bertelsen AS; Schytte T; Møller PK; Mahmood F; Riis HL; Gottlieb KL; Agergaard SN; Dysager L; Hansen O; Gornitzka J; Veldhuizen E; ODwyer DB; Christiansen RL; Nielsen M; Jensen HR; Brink C; Bernchou U
    Acta Oncol; 2019 Oct; 58(10):1352-1357. PubMed ID: 31241387
    [No Abstract]   [Full Text] [Related]  

  • 28. Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.
    Liu Q; Liang J; Zhou D; Krauss DJ; Chen PY; Yan D
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):985-997. PubMed ID: 29976511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Individual lymph nodes: "See it and Zap it".
    Winkel D; Werensteijn-Honingh AM; Kroon PS; Eppinga WSC; Bol GH; Intven MPW; de Boer HCJ; Snoeren LMW; Hes J; Raaymakers BW; Jürgenliemk-Schulz IM
    Clin Transl Radiat Oncol; 2019 Sep; 18():46-53. PubMed ID: 31341975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of delivered dose in prostate cancer patients treated with ultra-hypofractionated radiotherapy on 1.5-Tesla MR-Linac.
    Gao LR; Tian Y; Wang MS; Xia WL; Qin SR; Song YW; Wang SL; Tang Y; Fang H; Tang Y; Qi SN; Yan LL; Liu YP; Jing H; Chen B; Xing NZ; Li YX; Lu NN
    Front Oncol; 2023; 13():1039901. PubMed ID: 36741014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adaptive radiotherapy: The Elekta Unity MR-linac concept.
    Winkel D; Bol GH; Kroon PS; van Asselen B; Hackett SS; Werensteijn-Honingh AM; Intven MPW; Eppinga WSC; Tijssen RHN; Kerkmeijer LGW; de Boer HCJ; Mook S; Meijer GJ; Hes J; Willemsen-Bosman M; de Groot-van Breugel EN; Jürgenliemk-Schulz IM; Raaymakers BW
    Clin Transl Radiat Oncol; 2019 Sep; 18():54-59. PubMed ID: 31341976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Online Adaptive MRI-Guided Radiotherapy for Primary Tumor and Lymph Node Boosting in Rectal Cancer.
    Kensen CM; Betgen A; Wiersema L; Peters FP; Kayembe MT; Marijnen CAM; van der Heide UA; Janssen TM
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer.
    Da Silva Mendes V; Nierer L; Li M; Corradini S; Reiner M; Kamp F; Niyazi M; Kurz C; Landry G; Belka C
    Radiat Oncol; 2021 Jul; 16(1):133. PubMed ID: 34289868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimization of treatment planning workflow and tumor coverage during daily adaptive magnetic resonance image guided radiation therapy (MR-IGRT) of pancreatic cancer.
    Olberg S; Green O; Cai B; Yang D; Rodriguez V; Zhang H; Kim JS; Parikh PJ; Mutic S; Park JC
    Radiat Oncol; 2018 Mar; 13(1):51. PubMed ID: 29573744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial clinical experience of patient-specific QA of treatment delivery in online adaptive radiotherapy using a 1.5 T MR-Linac.
    Yang B; Wong YS; Lam WW; Geng H; Huang CY; Tang KK; Law WK; Ho CC; Nam PH; Cheung KY; Yu SK
    Biomed Phys Eng Express; 2021 Apr; 7(3):. PubMed ID: 33882471
    [No Abstract]   [Full Text] [Related]  

  • 36. Dosimetric comparison of glioblastoma radiotherapy treatment plans on a low-field MRI-guided linear accelerator compared to conventional C-arm linear accelerator.
    Moats E; Siddiqui MS; Parikh P; Snyder KC
    Med Dosim; 2024 Jan; ():. PubMed ID: 38233319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and validation of an MR-driven dose-of-the-day procedure for online adaptive radiotherapy in upper gastrointestinal cancer patients.
    Semeniuk O; Shessel A; Velec M; Fodor T; Rocca CC; Barry A; Lukovic J; Yan M; Mesci A; Kim J; Wong R; Dawson LA; Hosni A; Stanescu T
    Phys Med Biol; 2024 Jul; ():. PubMed ID: 39048106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of magnetic resonance-guided versus conventional radiotherapy workflows on organ at risk doses in stereotactic body radiotherapy for lymph node oligometastases.
    Werensteijn-Honingh AM; Kroon PS; Winkel D; van Gaal JC; Hes J; Snoeren LMW; Timmer JK; Mout CCP; Bol GH; Kotte AN; Eppinga WSC; Intven M; Raaymakers BW; Jürgenliemk-Schulz IM
    Phys Imaging Radiat Oncol; 2022 Jul; 23():66-73. PubMed ID: 35814260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of online adaptive MR-guided stereotactic body radiotherapy of liver cancers.
    Padgett KR; Simpson G; Asher D; Portelance L; Bossart E; Dogan N
    Phys Med; 2020 Sep; 77():54-63. PubMed ID: 32781388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dosimetric feasibility of brain stereotactic radiosurgery with a 0.35 T MRI-guided linac and comparison vs a C-arm-mounted linac.
    Slagowski JM; Redler G; Malin MJ; Cammin J; Lobb EC; Lee BH; Sethi A; Roeske JC; Flores-Martinez E; Stevens T; Yenice KM; Green O; Mutic S; Aydogan B
    Med Phys; 2020 Nov; 47(11):5455-5466. PubMed ID: 32996591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.